PSS3 INDUCTION COST PER RESPONDER OF BRODALUMAB COMPARED WITH OTHER BIOLOGICS APPROVED FOR PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN CANADA
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2565
https://www.valueinhealthjournal.com/article/S1098-3015(19)34943-5/fulltext
Title :
PSS3 INDUCTION COST PER RESPONDER OF BRODALUMAB COMPARED WITH OTHER BIOLOGICS APPROVED FOR PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN CANADA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34943-5&doi=10.1016/j.jval.2019.09.2565
First page :
Section Title :
Open access? :
No
Section Order :
12247